Issue link: https://viewer.e-digitaledition.com/i/459868
CONTINUED ON PAGE 10 TARGETED TEACHING= BETTER VOCABULARY SKILLS? Milieu Communication Teaching (MCT) is an early-intervention strategy aimed at improving communication skills in pre-K children who are developmentally delayed. Researchers at Vanderbilt University evaluated the effectiveness of MCT on vocabulary development in children with Down syndrome and children with other developmental disabilities over a period of nine months. Results revealed that children in both groups who received five one-hour MCT sessions per week experienced greater gains in vocabulary than their peers who only received one MCT session per week. Authors note, however, that benefits were somewhat dependent upon whether or not children were interested in playing with the objects presented during MCT sessions. American Journal on Intellectual and Developmental Disabilities, 2014 MEDICATION MAY REDUCE RSV-RELATED COMPLICATIONS Young children with Down syndrome have a higher risk of developing respiratory syncytial virus (RSV) and severe, RSV-related complications than typical children. Recent research reveals that taking palivizumab, a drug given via a monthly injection during the months when RSV infection is most common — usually November to April — may SCIENCE SNPS DOWN SYNDROME OCCURS when a person is born with three copies of chromosome 21 instead of two. Jeanne B. Lawrence, Ph.D., Chair of the Department of Cell and Developmental Biology at the University of Massachusetts Medical School, and her team successfully silenced, or shut down, the extra chromosome responsible for Down syndrome in cell cultures. Their work was published in Nature in 2013 and was funded by a National Institutes of Health high-risk, high-impact grant. Dr. Lawrence is part of a new cadre of researchers who are confident that Down syndrome is tractable and treatment can lead to improved quality of life for people with Down syndrome. "Initially, I had some parents who were concerned that research into chromosome silencing on the cellular level would allow us to change the nature of their child," Dr. Lawrence said. "We do not have the capacity or intent to do that. The goal of this new approach is to open possibilities of mitigating and helping the different medical challenges associated with Down syndrome. Mutating the extra copy of the 21st chromosome opens up a new avenue to seek therapies for cognitive delays, Alzheimer's disease, heart defects, and leukemia." A GROUNDBREAKING DISCOVERY It has long been known that the XIST gene that resides on the X chromosome silences one of the two X chromosomes carried by all female mammals, including humans. Dr. Lawrence and her team used induced pluripotent stem cells (iPSCs) to insert the XIST gene into the 21st chromosome that essentially turned off the third copy of the chromosome. This was not an easy task given that there were a number of challenging steps that could have resulted in failure. "Previously, there was no indication whether or not this could be done," said Tom Blumenthal, Ph.D., Anna and John J. Sie Professor in Genomics at the University of Colorado School of Medicine and Executive Director of the Linda Crnic Institute for Down Syndrome. "Dr. Lawrence was able to harness the power of something that already happens in our genetic code on chromosome X and use it to mute trisomy 21 at a cellular level. This is truly game-changing." RESEARCHERS AT THE UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL HAVE SUCCESSFULLY SILENCED THE EXTRA COPY OF CHROMOSOME 21. HERE'S WHAT IT COULD MEAN FOR THE FUTURE OF PEOPLE WITH DOWN SYNDROME. SILENCING THE EXTRA 21 ST CHROMOSOME IN DOWN SYNDROME Jeanne B. Lawrence, Ph.D. Continued on Page 10 WINTER2015 DOWN SYNDROME WORLD 8

